These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
482 related articles for article (PubMed ID: 24127302)
1. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia. Ong LY; Razak SN; Lee YM; Sri La Sri Ponnampalavanar S; Syed Omar SF; Azwa RI; Tee KK; Kamarulzaman A J Med Virol; 2014 Jan; 86(1):38-44. PubMed ID: 24127302 [TBL] [Abstract][Full Text] [Related]
2. Antiretroviral drug resistance and HIV-1 subtypes among treatment-naive prisoners in Kelantan, Malaysia. Ariffin TA; Mohamad S; Yusuf WN; Shueb RH J Infect Dev Ctries; 2014 Aug; 8(8):1063-7. PubMed ID: 25116676 [TBL] [Abstract][Full Text] [Related]
3. Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants. Wang B; Lau KA; Ong LY; Shah M; Steain MC; Foley B; Dwyer DE; Chew CB; Kamarulzaman A; Ng KP; Saksena NK Virology; 2007 Oct; 367(2):288-97. PubMed ID: 17604072 [TBL] [Abstract][Full Text] [Related]
4. Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia. Tee KK; Pon CK; Kamarulzaman A; Ng KP AIDS; 2005 Jan; 19(2):119-26. PubMed ID: 15668536 [TBL] [Abstract][Full Text] [Related]
5. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil. Cardoso LP; Queiroz BB; Stefani MM J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948 [TBL] [Abstract][Full Text] [Related]
6. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations. de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783 [TBL] [Abstract][Full Text] [Related]
7. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China. Liu J; Yue J; Wu S; Yan Y Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115 [TBL] [Abstract][Full Text] [Related]
8. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil. Ferreira AS; Cardoso LP; Stefani MM J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433 [TBL] [Abstract][Full Text] [Related]
9. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil. Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil. Cardoso LP; Pereira GA; Viegas AA; Schmaltz LE; Stefani MM J Med Virol; 2010 Mar; 82(3):351-7. PubMed ID: 20087934 [TBL] [Abstract][Full Text] [Related]
11. Primary HIV-1 drug resistance in the C-terminal domains of viral reverse transcriptase among drug-naïve patients from Southern Brazil. Santos AF; Silveira J; Muniz CP; Tornatore M; Góes LR; Mendoza-Sassi RA; Martinez AM; Tupinambás U; Greco DB; Soares MA J Clin Virol; 2011 Dec; 52(4):373-6. PubMed ID: 21975076 [TBL] [Abstract][Full Text] [Related]
12. Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland North State of Tocantins, Brazil. Carvalho BC; Cardoso LP; Damasceno S; Stefani MM AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1081-7. PubMed ID: 21417758 [TBL] [Abstract][Full Text] [Related]
13. Molecular diversity of HIV-1 among people who inject drugs in Kuala Lumpur, Malaysia: massive expansion of circulating recombinant form (CRF) 33_01B and emergence of multiple unique recombinant clusters. Chow WZ; Ong LY; Razak SH; Lee YM; Ng KT; Yong YK; Azmel A; Takebe Y; Al-Darraji HA; Kamarulzaman A; Tee KK PLoS One; 2013; 8(5):e62560. PubMed ID: 23667490 [TBL] [Abstract][Full Text] [Related]
14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
15. Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naïve Cameroonian subjects with advanced disease. Soares EA; Makamche MF; Siqueira JD; Lumngwena E; Mbuagbaw J; Kaptue L; Asonganyi T; Seuánez HN; Soares MA; Alemnji G J Clin Virol; 2010 Jul; 48(3):173-9. PubMed ID: 20483657 [TBL] [Abstract][Full Text] [Related]
16. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon. Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019 [TBL] [Abstract][Full Text] [Related]
17. Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients. Epaulard O; Signori-Schmuck A; Larrat S; Kulkarni O; Blum MG; Fusillier K; Blanc M; Leclercq P; François O; Morand P J Clin Virol; 2017 Oct; 95():13-19. PubMed ID: 28830014 [TBL] [Abstract][Full Text] [Related]
18. Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil. Santos LA; Monteiro-Cunha JP; Araujo AF; Brites C; Galvao-Castro B; Alcantara LC J Med Virol; 2011 Dec; 83(12):2066-72. PubMed ID: 22012712 [TBL] [Abstract][Full Text] [Related]
19. Assessing subtypes and drug resistance mutations among HIV-1 infected children who failed antiretroviral therapy in Kelantan, Malaysia. Mohamad S; Deris ZZ; Yusoff NK; Ariffin TA; Shueb RH Braz J Infect Dis; 2012; 16(3):284-8. PubMed ID: 22729198 [TBL] [Abstract][Full Text] [Related]
20. Screening for antiretroviral drug resistance among treatment-naive human immunodeficiency virus type 1-infected individuals in Lebanon. Mokhbat JM; Melhem NM; El-Khatib Z; Zalloua P J Infect Dev Ctries; 2014 Mar; 8(3):339-48. PubMed ID: 24619266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]